Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses

April 11, 2011 updated by: University of Kentucky

Center for the Biologic Basis of Oral/Systemic Diseases Project 5: Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses.

The purpose of this study is to test the hypothesis that dietary n-3 PUFA will have a beneficial effect on systemic and local markers of inflammation when combined with traditional, non-surgical periodontal therapy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Lexington, Kentucky, United States, 40536
        • University of Kentucky College of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. ≥ 18 years of age, male or female
  2. At least 20 natural teeth present at the time of periodontal examination
  3. Be diagnosed with severe, chronic periodontitis;
  4. Be willing to participate in the study

Exclusion Criteria:

  1. <18 years of age
  2. Less than 20 natural teeth present at time of periodontal examination
  3. Unable or unwilling to provide informed consent or follow study protocol
  4. Systemic conditions including diabetes mellitus and any cardiovascular condition that would require premedication prior to dental treatment
  5. Use of systemic antibiotics within the last 3 months
  6. Pregnancy as diagnosed by administered pregnancy test.
  7. You are nursing a baby.
  8. Are allergic to fish or fish products.
  9. You are taking any other medications, such as dietary supplements, that could affect the outcome of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
corn/soybean oil capsules 1g/three times daily
Active Comparator: Fish oil
1000mg capsules three times daily, duration 28 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
clinical attachment loss
Time Frame: baseline, 8, 16, 28 weeks
baseline, 8, 16, 28 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dolph R. Dawson, DMD,MS, University of Kentucky College of Dentistry
  • Study Chair: Jeff L. Ebersole, Ph.D, University of Kentucky College of Dentistry
  • Study Director: M J Novak, Ph.D, University of Kentucky College of Dentistry
  • Study Director: Gilbert A. Boissonneault, Ph.D, University of Kentucky Division of Clinical Nutrition

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2004

Primary Completion (Actual)

May 1, 2009

Study Completion (Actual)

May 1, 2009

Study Registration Dates

First Submitted

February 29, 2008

First Submitted That Met QC Criteria

March 10, 2008

First Posted (Estimate)

March 11, 2008

Study Record Updates

Last Update Posted (Estimate)

April 12, 2011

Last Update Submitted That Met QC Criteria

April 11, 2011

Last Verified

April 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • UK IRB # 04-0339-F1V
  • P20RR020145-04 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Attachment Loss

Clinical Trials on Omega-3 Fatty acid (with SRP or OHI)

3
Subscribe